New Pharma Tech Survey: Hear from 100+ Investors and Entrepreneurs LEARN MORE

McKesson Ventures
  • Portfolio
  • News & Insights
  • Team
  • About Us
    • Our Approach
    • About McKesson
    • Contact Us

Merck Digital Sciences Studio’s SciMar ONE is already demonstrating early value

by McKesson Ventures | Jun 29, 2023 | Media Coverage, Portfolio News

Last year, McKesson Ventures joined a group of funders including Merck, Microsoft, the Global Health Innovation Fund, Northpond Ventures, and the New Jersey Institute of Technology to bring to life a “founder-friendly” startup accelerator for companies in the...

‘A Startup Supporting Startups’: Inside Merck Digital Sciences Studio

by McKesson Ventures | Jun 1, 2023 | Portfolio News

Last year, McKesson Ventures joined Merck, Microsoft, the Global Health Innovation Fund, Northland Ventures, and the New Jersey Institute of Technology to create the Merck Digital Sciences Studio. The studio was inspired by the work of Geof Hannigan, a computational...

Recent Posts

  • Komodo Health Wins 2026 Fierce AI Innovation Award for Commercial Strategy & Launch from Fierce Pharma
  • Silver and LYNX Launch Production AI Claims Automation to Help TPAs Modernize Claims Processing
  • HarmonyCares Ranks Among Medicare’s Top ACO REACH Performers for 2024
  • UNC Health Scales Medication Access By Over 45% Without Adding Headcount Using Latent Health’s Pharmacy Intelligence Platform
  • Reimagine Care Expands AI-Enabled Virtual Oncology Model with Moffitt Cancer Center Following Strong Patient and Clinical Outcomes
McKesson Ventures

One Post Street, 21st Floor
San Francisco, CA 94104

IN THE NEWS

ABOUT US

CONTACT US

  • Follow
©2026 McKesson Ventures | Privacy Notice | Disclaimer | Cookie Settings
McKesson Ventures

One Post Street, 21st Floor
San Francisco, CA 94104

©2026 McKesson Ventures | Privacy Notice | Disclaimer | Cookie Settings